TB-500 (Thymosin Beta-4) 20mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of TB-500 supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.

Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.

Batch: GF-TB50020-B241

Key analytical results include:

• Assay Content: 22.0 mg
• Identification – Retention Time: 0.995
• Identification – Spectrum: 996
• Purity: greater than 99.8 percent
• Bacterial Endotoxins: below 0.001 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium.

These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.

Product Overview

TB-500 is a synthetic peptide research compound derived from the naturally occurring protein fragment Thymosin Beta-4. It is frequently studied in controlled laboratory environments investigating peptide-mediated cellular signalling and tissue regulatory pathways.

The peptide belongs to a class of actin-binding regulatory proteins involved in cellular migration, cytoskeletal organization and intracellular signalling mechanisms.

This preparation contains 20 mg of high purity lyophilized peptide supplied in a sealed research vial. The lyophilization process preserves peptide stability and allows researchers to reconstitute the compound for controlled in vitro experimentation.

Because of its defined peptide structure and stable analytical profile, TB-500 has become a widely referenced compound in experimental peptide and cellular signalling research models.

Compound Overview

TB-500 is a synthetic version of a biologically active fragment of Thymosin Beta-4, a peptide naturally present in many mammalian tissues.

Thymosin Beta-4 interacts with actin, a structural protein responsible for cytoskeletal organization, intracellular transport and cellular movement.

Research involving TB-500 frequently explores peptide-mediated cellular migration pathways, cytoskeletal regulation and molecular signalling networks.

Due to its defined molecular structure, TB-500 is widely utilised in laboratory research investigating cellular regulatory processes and peptide signalling dynamics.

Historical Background and Scientific Context

Scientific research into Thymosin Beta-4 began during the late twentieth century when researchers identified thymosin peptides involved in cellular regulatory systems.

Further investigation revealed that fragments of the Thymosin Beta-4 peptide interact with actin-binding pathways that influence cellular migration and cytoskeletal organization.

Advances in peptide synthesis allowed scientists to develop synthetic analogues such as TB-500 in order to study these molecular pathways under controlled laboratory conditions.

Since then, TB-500 has been used in experimental models exploring peptide signalling mechanisms and cellular regulatory networks.

Mechanistic Focus in Research

Within experimental laboratory settings, TB-500 is commonly studied in relation to actin interaction pathways and cellular regulatory signalling mechanisms.

Research investigations commonly explore the compound in experimental models examining:

• Actin-binding protein interactions
• Cellular migration signalling pathways
• Cytoskeletal organization processes
• Peptide-mediated intracellular signalling networks
• Comparative peptide interaction research
• Molecular regulatory pathway modelling
• Cellular structural protein dynamics

These experimental models allow scientists to investigate molecular mechanisms that regulate cellular structure, movement and biochemical signalling processes.

Research Applications

In controlled research environments, TB-500 may be utilised in experimental models designed to explore peptide-mediated cellular regulatory systems.

Examples of research applications include:

• Cell migration research models
• Cytoskeletal regulation studies
• Actin-binding protein interaction analysis
• Molecular signalling pathway investigation
• Comparative peptide compound evaluation
• Intracellular regulatory network modelling
• Controlled in vitro peptide studies

Grail Formula Quality

Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation.

Each batch undergoes independent analytical testing to verify:

• Compound identity
• Assay accuracy
• Purity confirmation
• Microbial safety
• Endotoxin levels
• Heavy metal screening
• Full batch traceability

All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.

Research Use Limitation

• Used solely for in vitro experiments
• Not permitted for clinical trials involving humans
• Not permitted for human or veterinary administration
• Not permitted for investigational human use

Independently verified by Liquilabs s.r.o. (Czechia)
Validated assay content 22.0 mg
Purity greater than 99.8 percent
Retention time and spectral identity confirmation
Endotoxin levels below 0.001 EU per mg
No detectable microbial contamination
No detectable heavy metals
For research use only — not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.